Human embryonic stem cells passaged using enzymatic methods retain a normal karyotype and express CD30

Cloning and Stem Cells

Volumn 10, Issue 1, 2008, Pages 89-105

  Thomson, Alison ^a   Wojtacha, Davina ^a   Hewitt, Zoë ^a,b   Priddle, Helen ^a,c   Sottile, Virginie ^a,c   Di Domenico, Alex ^a   Fletcher, Judy ^a,d   Waterfall, Martin ^a   Corrales, Néstor López ^a,e   Ansell, Ray ^a   Mcwhir, Jim ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b UNIVERSITY OF SHEFFIELD   (United Kingdom)

^c UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^d UNIVERSITY OF EDINBURGH   (United Kingdom)

^e PUBLIC UNIVERSITY OF NAVARRE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; CD30 ANTIGEN; CHELATING AGENT; COLLAGENASE; EDETIC ACID; EGTAZIC ACID; TRYPSIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; CELL AGGREGATION; CELL CULTURE; CELL DISSOCIATION; CELL ISOLATION; CELL MANIPULATION; CELL SEPARATION; CELL SUSPENSION; CHROMOSOME REARRANGEMENT; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; EMBRYO; EMBRYONAL CARCINOMA; EMBRYONIC STEM CELL; ENZYME CHEMISTRY; HUMAN; HUMAN CELL; ISOCHROMOSOME; KARYOTYPE; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; TELOMERE;

ANTIGENS, CD30; CELL CULTURE TECHNIQUES; CELL DIFFERENTIATION; CELL PROLIFERATION; CELLS, CULTURED; CHROMOSOME BANDING; COLLAGENASES; EGTAZIC ACID; EMBRYONIC STEM CELLS; GENOME, HUMAN; HUMANS; K562 CELLS; KARYOTYPING; MODELS, BIOLOGICAL; TRYPSIN;

EID: 40349098666     PISSN: 15362302     EISSN: None     Source Type: Journal    
DOI: 10.1089/clo.2007.0072     Document Type: Article

References (31)

1. Amit, M., Carpenter, M.K., Inokuma, M.S., et al. (2000). Clonally derived human embryonic stem cell lines maintain pluripotency and proliferative potential for prolonged periods of culture. Dev. Biol. 227, 271-278.
2. Brimble, S.N., Zeng, X., Weiler, D.A., et al. (2004). Karyotypic stability, genotyping, differentiation, feeder-free maintenance, and gene expression sampling in three human embryonic stem cell lines derived prior to August 9, 2001. Stem Cells Dev. 13, 585-597.
3. Buzzard, J.J., Gough, N.M., Crook, J.M., et al. (2004). Karyotype of human ES cells during extended culture. Nat. Biotechnol. 22, 381-382.
4. Draper, J.S., Smith, K., Gokhale, P., et al. (2004). Recurrent gain of chromosomes 17q and 12 in cultured human embryonic stem cells. Nat. Biotechnol. 22, 53-54.
5. Durkop, H., Latza, U., Hummel, M., et al. (1992). Molecular cloning and expression of a new member of the nerve growth factor receptor family that is characteristic for Hodgkin's disease. Cell 68, 421-427.
6. Durkop, H., Foss, H.D., Eitelbach, F., et al. (2000). Expression of the CD30 antigen in non-lymphoid tissues and cells. J. Pathol. 190, 613-618.
7. Enver, T., Soneji, S., Joshi, C., et al. (2005). Cellular differentiation hierarchies in normal and culture-adapted human embryonic stem cells. Hum. Mol. Genet. 14, 3129-3140.
8. Fletcher, J.M., Ferrier, P.M., Gardner, J.O., et al. (2006). Variations in humanized and defined culture conditions supporting derivation of new human embryonic stem cell lines. Cloning Stem Cells. 8, 319-334.
9. Forsyth, N.R., Musio, A., Vezzoni, P., et al. (2006). Physiologic oxygen enhances human embryonic stem cell clonal recovery and reduces chromosomal abnormalities. Cloning Stem Cells 8, 16-23.
10. Gallimore, P.H., and Richardson, C.R. (1973). An improved banding technique exemplified in the karyotype analysis of two strains of rat. Chromosoma 41, 259-263.
11. Hasegawa, K., Fujioka, T., Nakamura, Y., et al. (2006). A method for the selection of human embryonic stem cell sub-lines with high replating efficiency after single cell dissociation. Stem Cells 24, 2649-2660.
12. Herszfeld, D., Wolvvetang, E., Langton-Bunker, E., et al. (2006). CD30 is a survival factor and a biomarker for transformed human pluripotent stem cells. Nat. Biotechnol. 24, 351-357.
13. Hewitt, Z., Forsyth, N., Waterfall, M., et al. (2006). Fluorescence-activated single cell sorting of human ES cells. Cloning Stem Cells 8, 225-234.
14. Hewitt, Z., Priddle, H., Thomson, A.J., et al. (2007). Ablation of undifferentiated human embryonic stem cells by exploiting innate immunity against the α-galactosyltransferase epitope. Stem Cells 25, 10-18.
15. Inzunza, J., Sahlen, S., Holmberg, K., et al. (2004). Comparative genomic hybridization and karyotyping of human embryonic stem cells reveals the occurrence of an isodicentric x chromosome after long-term cultivation. Mol. Hum. Genet. 10, 461-466.
16. Kallioniemi, A., Kallioniemi, O.P., Sudar, D., et al. (1992). Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors. Science 258, 818-821.
17. Kallioniemi, O.P., Kallioniemi, A., Piper, J., et al. (1994). Optimizing comparative genomic hybridization for analysis of DNA sequence copy number changes in solid tumors. Genes Chromosome Cancer 10, 231-243.
18. Ludwig, T.E., Levenstein, M.E., Jones, J.M., et al. (2006). Derivation of human embryonic stem cells in defined conditions. Nat. Biotechnol. 24, 185-187.
19. McWhir, J., Schnieke, A.E., Ansell, R., et al. (1996). Selective ablation of differentiated cells permits isolation of embryonic stem cell lines from murine embryos with a non-permissive genetic background. Nat. Genet. 14, 223-226.
20. McWhir, J., Wojtacha, D., and Thomson, A.J. (2006). Routine culture and differentiation of human embryonic stem cells. In Human Embryonic Stem Cells Protocols: Methods in Molecular Biology, vol. 331. K. Turksen, ed. (Humana Press, Clifton, NJ) pp. 77-90.
21. Maitra, A., Arking, D.E., Shivapurkar, N., et al. (2005). Genomic alterations in cultured human embryonic stem cells. Nat. Genet. 37, 1099-1103.
22. Mitalipova, M.M., Rao, R.R., Hover, D.M., et al. (2005). Preserving the genetic integrity of human embryonic stem cells. Nat. Biotechnol. 23, 19-20.
23. Pera, M.F., Bennett, W., and Cerretti, D.P. (1997). Expression of CD30 and CD30 ligand in cultured cell lines from human germ-cell tumors. Lab Invest. 76, 497-504.
24. Priddle, H. (2004). Transfection of human embryonic stem cells. In Gene Targeting and Stem Cells: Advanced Methods. A.J. Thomson and J. McWhir, eds. (Garland Science/BIOS Scientific Publications, New York), pp. 171-202.
25. Rosler, E.S., Fisk, G.J., Ares, X., et al. (2004). Long-term culture of human embryonic stem cells in feeder-free conditions. Dev. Dynam. 229, 259-274.
26. Schuldiner, M., Itskovitz-Eldor, J., and Benvenisty, N. (2003). Selective ablation of human embryonic stem cells expressing a "suicide" gene. Stem Cells 21, 257-265.
27. Siemen, H., Nix, M., Endl, E., et al. (2005). Nucleofection of human embryonic stem cells. Stem Cells Dev. 14, 378-383.
28. Sottile, V., Halleux, C., Bassilana, F., et al. (2002). Stem cell characteristics of human trabecular bone derived cells. Bone 30, 699-704.
29. Thomson, J.A., Itskovitz-Eldor, J., Shapiro, S.S., et al. (1998). Embryonic stem cell lines derived from human blastocysts. Science 282, 1145-1147.
30. Xu, C., Inokuma, M.S., Denham, J., et al. (2001). Feeder-free growth of undifferentiated human embryonic stem cells. Nat. Biotechnol. 19, 971-974.
31. Zwaka, T.P., and Thomson, J.A. (2003). Homologous recombination in human embryonic stem cells. Nat. Biotechnol. 21, 319-321.